Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction
Authors:
- Roberto MarchioliRMRoberto Marchioli
- Federica BarziFBFederica Barzi
- Elena BombaEBElena Bomba
- Carmine ChieffoCCCarmine Chieffo
- Domenico Di GregorioDGDomenico Di Gregorio
- Rocco Di MascioRMRocco Di Mascio
- Maria Grazia FranzosiMFMaria Grazia Franzosi
- Enrico GeraciEGEnrico Geraci
- Giacomo LevantesiGLGiacomo Levantesi
- Aldo Pietro MaggioniAldo Pietro Maggioni
- Loredana MantiniLMLoredana Mantini
- Rosa Maria MarfisiRMRosa Maria Marfisi
Top Cited Papers
- 23 April 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (16) , 1897-1903
Abstract
Background — Our purpose was to assess the time course of the benefit of n-3 polyunsaturated fatty acids (PUFAs) on mortality documented by the GISSI-Prevenzione trial in patients surviving a recent ( Methods and Results — In this study, 11 323 patients were randomly assigned to supplements of n-3 PUFAs, vitamin E (300 mg/d), both, or no treatment (control) on top of optimal pharmacological treatment and lifestyle advice. Intention-to-treat analysis adjusted for interaction between treatments was carried out. Early efficacy of n-3 PUFA treatment for total, cardiovascular, cardiac, coronary, and sudden death; nonfatal myocardial infarction; total coronary heart disease; and cerebrovascular events was assessed by right-censoring follow-up data 12 times from the first month after randomization up to 12 months. Survival curves for n-3 PUFA treatment diverged early after randomization, and total mortality was significantly lowered after 3 months of treatment (relative risk [RR] 0.59; 95% CI 0.36 to 0.97; P =0.037). The reduction in risk of sudden death was specifically relevant and statistically significant already at 4 months (RR 0.47; 95% CI 0.219 to 0.995; P =0.048). A similarly significant, although delayed, pattern after 6 to 8 months of treatment was observed for cardiovascular, cardiac, and coronary deaths. Conclusions — The early effect of low-dose (1 g/d) n-3 PUFAs on total mortality and sudden death supports the hypothesis of an antiarrhythmic effect of this drug. Such a result is consistent with the wealth of evidence coming from laboratory experiments on isolated myocytes, animal models, and epidemiological and clinical studies.Keywords
This publication has 24 references indexed in Scilit:
- Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations; GISSI-Prevenzione mortality risk chartEuropean Heart Journal, 2001
- A clinical appraisal of left atrial functionEuropean Heart Journal, 2001
- Effects of dietary fish oil on ventricular premature complexesThe American Journal of Cardiology, 1995
- Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkeyAmerican Heart Journal, 1992
- Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up.BMJ, 1992
- EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART)The Lancet, 1989
- The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart DiseaseNew England Journal of Medicine, 1985
- The 2 × 2 factorial design: Its application to a randomized trial of aspirin and U.S. physiciansStatistics in Medicine, 1985
- Epidemiological Studies in the Upernavik District, GreenlandActa Medica Scandinavica, 1980
- The Composition of Food Consumed by Greenland EskimosActa Medica Scandinavica, 1976